Literature DB >> 18257343

[Multi-central clinical evaluation of ginger-partitioned moxibustion for treatment of leukopenia induced by chemotherapy].

Xi-Xin Zhao1, Mei Lu, Xia Zhu, Ping Gao, Yan-Li Li, Xue-Mei Wang, Dong-Yang Ma, Xian-Hui Guo, Bo-Ying Tong, Xiao-Li Yang, Wei-Wei Du, Shi-Fan Zhou, Huai-Min Liu, Peng-Fei Ran, Xiao-Rui Lü.   

Abstract

OBJECTIVE: To prove the therapeutic effect of ginger-partitioned moxibustion on leukopenia induced by chemotherapy and effect on life quality of the patient with tumor after chemotherapy.
METHODS: Randomized, controlled, multi-central cooperative method was used and the patients confirmed to the enrolled criteria were divided in-to two groups. The test group were treated with ginger-partitioned moxibustion at Dazhui (GV 14), Geshu (BL 17), Pishu (BL 20), etc.; and the control group with oral administration of Chinese patent medicine.
RESULTS: Out of the 221 cases confirmed to program analysis, 113 cases were in the test group and 108 cases in the control group. After 10 days, the cured rate and the effective rate were 84.1% and 66.4% in the test group and 35.2% and 33.3% in the control group, respectively, with very significant differences between the two groups (both P < 0.01); fifteen days later, the therapeutic effects in the two groups were maintained. The two methods could improve clinical symptoms, with the test group being better than the control group. Any adverse response was not found in the two groups, and the injuries of functions of the heart, lung and kidney induced by chemotherapy had some improvement.
CONCLUSION: The therapeutic effect of ginger-partitioned moxibustion on luekopenia induced by chemotherapy is reliable and is better than oral administration of Chinese patent medicine, with a better duplication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18257343

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  6 in total

Review 1.  Moxibustion for the treatment of chemotherapy-induced leukopenia: a systematic review of randomized clinical trials.

Authors:  Tae-Young Choi; Myeong Soo Lee; Edzard Ernst
Journal:  Support Care Cancer       Date:  2014-12-05       Impact factor: 3.603

2.  The effect of different laser irradiation on cyclophosphamide-induced leucopenia in rats.

Authors:  Jizhong Zhao; Ke Cheng; Haiping Deng; Ling Zhao; Lanlan Liu; Menghu Guo; Haimeng Zhang; Xueyong Shen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-14       Impact factor: 2.629

3.  How does moxibustion possibly work?

Authors:  Jen-Hwey Chiu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

4.  The effectiveness of moxibustion: an overview during 10 years.

Authors:  Song-Yi Kim; Younbyoung Chae; Seung Min Lee; Hyejung Lee; Hi-Joon Park
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

5.  Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer.

Authors:  Hong Wei Zhang; Zhi Xiu Lin; Fan Cheung; William Chi-Shing Cho; Jin-Ling Tang
Journal:  Cochrane Database Syst Rev       Date:  2018-11-13

6.  The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.

Authors:  Yajie Ji; Siyu Li; Xinyue Zhang; Yu Liu; Qing Lu; Qiong Li; Weili Chen; Jiayu Sheng; Ke Jiang; Hongli Liang; Shanyan Sha; Mengting Li; Zongxin Chen; Peiyi Zheng; Minhong Wang; Yuanyuan Feng; Lei Wang; Huangan Wu; Huirong Liu; Yan Huang; Zhiguang Yin; Xiaohong Xue
Journal:  Trials       Date:  2020-10-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.